CELGENE ALPINE INVEST COMPANY II LLC has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), Canada and Mexico. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are PROMISING FUTURE LLC, TONGJI HOSP TONGJI MED UNIV and ASTERIAS BIOTHERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Canada | 2 | |
#3 | Mexico | 2 | |
#4 | Brazil | 1 | |
#5 | Chile | 1 | |
#6 | Colombia | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Cline Gary Allan | 6 |
#2 | Rossiter Guillermo | 6 |
#3 | Martin Philippe L | 6 |
#4 | Li Xiaobin | 6 |
#5 | Smith Scott Andrew | 6 |
#6 | Dewacker Seth R | 6 |
#7 | Usiskin Keith | 6 |
#8 | Keith Usiskin | 2 |
#9 | Seth R Dewacker | 2 |
#10 | Gary Allan Cline | 2 |
Publication | Filing date | Title |
---|---|---|
BR112017013765A2 | methods for using smad7 antisense oligonucleotides |